CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Syneos Health and Science 37 Announce Strategic Partnership

Syneos Health and Science 37 Announce...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Avance Appoints New Business Development Manager APAC

Avance Appoints New Business...

The Growing Demand for Contract Research Organizations

The Growing Demand for Contract...

The Potential for Artificial Intelligence in Clinical Trials

The Potential for Artificial...

Craig Lipset Joins Member and Executive Advisor of MedVector

Craig Lipset Joins Member and...

Processa to Join Russell Microcap Index

Life Sciences Review Life Sciences Review | Wednesday, June 16, 2021
Tweet

The membership of FTSE Russell's Russell indexes is determined mainly by objective market-capitalization rankings and style criteria.


FREMONT, CA: Processa Pharmaceuticals, a clinical-stage biopharmaceutical firm developing products to improve the survival and quality of life for patients who have unmet medical requirements is set to join the Russell MicrocapIndex following the 2021 Russell indexes annual reconstitution effect after the U.S. market opens on June 28, according to a preliminary list of attachments posted June 4.


A one-year membership in the Russell Microcap Index entitles one to automatic participation in the appropriate growth and value style indexes. The membership of FTSE Russell's Russell indexes is determined mainly by objective market-capitalization rankings and style criteria.


"Inclusion in this index is an important milestone for our company, one that we believe will increase our exposure within the investment community and provide us with a meaningful opportunity to reach new investors, particularly those who use the Russell indexes to benchmark their portfolios," said Dr. David Young, CEO, and Chairman, Processa.


Investment managers and institutional investors employ Russell indexes for index funds and as benchmarks for active investment strategies. Russell’s U.S. indices are used to benchmark about 10.6 trillion dollars in assets. FTSE Russell, a famous global index provider, produces Russell indexes.


Weekly Brief

loading
Top 10 CROs - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/processa-to-join-russell-microcap-index-nwid-397.html